About Genome Canada
Genome Canada is a not-for-profit organization, created by the Government of Canada in February 2000, which acts as a catalyst for developing and applying genomics and genomic-based technologies to create economic and social benefits for Canadians. Genome Canada connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation, and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance.
Genome Canada strategic plan 2012-2017 is bolstered by a new vision, mission and set of objectives appropriate for the next five years and reflective of the enormous promise that genomics offers.
Together with its six Genome Centres and with other partners, Genome Canada invests in and manages large-scale research projects in key selected areas such as agriculture, environment, fisheries, forestry, health and new technology development. Genome Canada also supports research projects aimed at studying and analyzing the ethical, environmental, economic, legal and social issues related to genomics research (GE3LS). In addition, five science & technology (S&T) innovation centres with cutting edge technical capabilities have been put in place across Canada to support the large-scale projects.
Funding structure and reporting
Projects and S&T innovation centres are selected based on their international competitiveness and scientific excellence in the framework of Canada's social and economic fabric. McGill is the host and major contributor to one of these platform services: the McGill University and Genome Quebec Innovation centre.
Federal government investments in Genome Canada total $915 million as of March 31, 2010. This investment represents 50 per cent of the funding of research projects and technology innovation centres. The agreement with the Government of Canada stipulates that Genome Canada will raise the other 50 per cent of funding from other sources. Once a competition is launched, all applications are submitted via the corresponding Genome Centre of the Lead Project investigator: Genome Quebec, in our case. (Genome Quebec will generally also contribute from 25% to 35% of the total cost of the project.)
Genome Canada undertakes an interim review of each approved project and science and technology platform within approximately eighteen months from the start date. The interim review is one of the oversight methods used in Genome Canada-funded projects and platforms. For projects, it is used to evaluate the progress of the research including GE3LS.
For the general guidelines that apply to all projects funded by Genome Canada, please consult the Genome Canada 2014 Guidelines.